CLINICAL RESEARCH
What is the Prognostic Value of Myocardial Perfusion Imaging Using Rubidium-82 Positron Emission Tomography?
Keiichiro Yoshinaga, MD,
Benjamin J.W. Chow, MD,
Kathryn Williams, MS,
Li Chen, MSc,
Robert A. deKemp, PhD,
Linda Garrard, RN, BScN,
Alexander Lok-Tin Szeto, MD,
May Aung, RT,
Ross A. Davies, MD,
Terrence D. Ruddy, MD and
Rob S.B. Beanlands, MD*
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Manuscript received October 3, 2005;
revised manuscript received January 26, 2006,
accepted March 7, 2006.
* Reprint requests and correspondence: Dr. Rob S. B. Beanlands, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, Canada K1Y 4W7 (Email: rbeanlands{at}ottawaheart.ca).
OBJECTIVES: The objective was to determine the prognostic value of rubidium-82 (82Rb) positron emission tomography (PET) myocardial perfusion imaging (MPI).
BACKGROUND: 82Rb PET MPI accurately diagnoses coronary artery disease (CAD). However, there are limited data evaluating its prognostic value.
METHODS: Follow-up (3.1 ± 0.9 years) was obtained in 367 patients who underwent dipyridamole 82Rb PET MPI. Patients were divided into groups based on their summed stress score (SSS): group I, normal (<4); group II, mild (4 to 7); and group III, moderate (8 to 11) to severe ( 12).
RESULTS: There were significant differences among patients in the 3 SSS groups for hard events (cardiac death and myocardial infarction [MI]) (p < 0.001) and total cardiac events (hard events, revascularization and hospitalization) (p < 0.001). The annual hard events rates were 0.4%, 2.3%, and 7.0% in the normal, mild, and moderate-severe groups, respectively. In adjusted survival models, 82Rb PET SSS was the strongest predictor of total cardiac events and a significant predictor of hard events. Among patients referred for PET after 99mTc single-photon emission computed tomography, the annual total event rate was higher with abnormal versus normal SSS on PET (15.2% vs. 1.3%, p < 0.001). In patients with obesity, the annual total event rate was 11.1% with an abnormal scan and 1.5% with a normal scan (p < 0.001).
CONCLUSIONS: This study shows that 82Rb PET MPI has significant prognostic value for predicting cardiac events, including death and MI. It also seems to have prognostic value in patients whose diagnosis remains uncertain after single-photon emission computed tomography MPI and in obese patients. The prognostic value of PET MPI may improve the management of cardiac patients.
|
Abbreviations and Acronyms
| | BMI = body mass index | | CABG = coronary artery bypass grafting | | CAD = coronary artery disease | | MI = myocardial infarction | | MPI = myocardial perfusion imaging | | PCI = percutaneous coronary intervention | | PET = positron emission tomography | | 82Rb = rubidium-82 | | SDS = summed difference score | | SPECT = single-photon emission computed tomography | | SRS = summed rest score | | SSS = summed stress score |
|
This article has been cited by other articles:
|
|
|
|
 
A. L. Baggish and C. A. Boucher
Radiopharmaceutical Agents for Myocardial Perfusion Imaging
Circulation,
October 14, 2008;
118(16):
1668 - 1674.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Chander, M. Brenner, R. Lautamaki, C. Voicu, J. Merrill, and F. M. Bengel
Comparison of Measures of Left Ventricular Function from Electrocardiographically Gated 82Rb PET with Contrast-Enhanced CT Ventriculography: A Hybrid PET/CT Analysis
J. Nucl. Med.,
October 1, 2008;
49(10):
1643 - 1650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, and S. Sdringola
Reducing Radiation Dose in Rest-Stress Cardiac PET/CT by Single Poststress Cine CT for Attenuation Correction: Quantitative Validation
J. Nucl. Med.,
May 1, 2008;
49(5):
738 - 745.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Vesely and V. Dilsizian
Nuclear Cardiac Stress Testing in the Era of Molecular Medicine
J. Nucl. Med.,
March 1, 2008;
49(3):
399 - 413.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Knuuti and F M Bengel
Positron emission tomography and molecular imaging
Heart,
March 1, 2008;
94(3):
360 - 367.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Bateman
Business Aspects of Cardiovascular Computed Tomography: Tackling the Challenges
J. Am. Coll. Cardiol. Img.,
January 1, 2008;
1(1):
111 - 118.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. L. Gould
Not All Randomized Trials Are Equal
J. Am. Coll. Cardiol.,
November 13, 2007;
50(20):
2013 - 2015.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol.,
September 4, 2007;
50(10):
988 - 1003.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, A. Guha, and S. Sdringola
Frequent Diagnostic Errors in Cardiac PET/CT Due to Misregistration of CT Attenuation and Emission PET Images: A Definitive Analysis of Causes, Consequences, and Corrections
J. Nucl. Med.,
July 1, 2007;
48(7):
1112 - 1121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. F. Di Carli, S. Dorbala, J. Meserve, G. El Fakhri, A. Sitek, and S. C. Moore
Clinical Myocardial Perfusion PET/CT
J. Nucl. Med.,
May 1, 2007;
48(5):
783 - 793.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. F. Di Carli and R. Hachamovitch
New Technology for Noninvasive Evaluation of Coronary Artery Disease
Circulation,
March 20, 2007;
115(11):
1464 - 1480.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
|
|
|
